EV/EBITDA
-16.26
+0.48+2.87%
1 min ago
Summary
- As of February 25, 2025, ESPR EV/EBITDA is -16.26, with a rise of +0.48 (+2.87%) during the most recent trading day.
- Over the past year, ESPR EV/EBITDA has dropped by -11.74 (-259.73%).
- ESPR EV/EBITDA is now -1277.97% below its all-time high of -1.18.
Performance
ESPR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ESPR EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.9% | -2.9% | -3.8% |
| 1 m1 month | +13.1% | -13.1% | -17.1% |
| 3 m3 months | +24.4% | -24.4% | -30.6% |
| 6 m6 months | -54.1% | +9.3% | -1.7% |
| ytdytd | +15.9% | -15.9% | -20.4% |
| 1 y1 year | -259.7% | -30.8% | -34.5% |
| 5 y5 years | +2.8% | -68.4% | -97.1% |
ESPR EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -18.72 | +13.1% | |
| 3 m | 3-month | -16.26 | at high | -30.74 | +47.1% |
| 6 m | 6-month | -9.78 | -66.3% | -30.74 | +47.1% |
| 1 y | 1-year | -3.75 | -333.6% | -30.74 | +47.1% |
| 3 y | 3-year | -1.21 | -1243.8% | -30.74 | +47.1% |
| 5 y | 5-year | -1.18 | -1278.0% | -30.74 | +47.1% |
| alltime | all time | -1.18 | -1278.0% | -61.85 | +73.7% |
Esperion Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.26(-15.9%) |
| 2024 | -19.34(+437.2%) |
| 2023 | -3.60(+3.7%) |
| 2022 | -3.47(+116.9%) |
| 2021 | -1.60(-65.3%) |
| 2020 | -4.61(-72.3%) |
| Date | Value |
|---|---|
| 2019 | -16.63(+182.3%) |
| 2018 | -5.89(-42.3%) |
| 2017 | -10.20(+207.2%) |
| 2016 | -3.32(-62.0%) |
| 2015 | -8.73(-57.7%) |
| 2014 | -20.66(+235.9%) |
| 2013 | -6.15 |
FAQ
- What is Esperion Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Esperion Therapeutics?
- What is ESPR EV/EBITDA year-to-date change?
- What is Esperion Therapeutics EV/EBITDA year-on-year change?
What is Esperion Therapeutics EV/EBITDA?
The current EV/EBITDA of ESPR is -16.26
What is the all time high EV/EBITDA for Esperion Therapeutics?
Esperion Therapeutics all-time high EV/EBITDA is -1.18
What is ESPR EV/EBITDA year-to-date change?
Esperion Therapeutics EV/EBITDA has changed by +3.08 (+15.93%) since the beginning of the year
What is Esperion Therapeutics EV/EBITDA year-on-year change?
Over the past year, ESPR EV/EBITDA has changed by -11.74 (-259.73%)